Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07552857 · ClinicalTrials.gov registry record · NA

A Vaccine Communication Training Intervention for Pediatric Inpatient Clinicians

A NA study, sponsored by Seattle Children's Hospital.

Not yet
Registry status
NA
Development phase
2,000
Enrollment target

NCT07552857: Clinical Trial NA study, sponsored by Seattle Children's Hospital.

NCT07552857 is a NA study that has not yet begun recruiting, run by Seattle Children's Hospital. The registered enrollment target is 2,000 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07552857, a NA study, has not yet begun recruiting, sponsored by Seattle Children's Hospital.

NOT YET RECRUITING
Registry status
NA
Development phase
2,000 participants
Enrollment target

Study Summary

This study will examine a novel stakeholder-informed intervention to identify vaccine-eligible children and promote evidence-based clinician vaccine communication with families with the goal of increasing vaccine uptake during hospitalization.

Primary Outcome

The percentage of vaccine-eligible hospitalized patients who receive one or more needed routine childhood vaccines (non-influenza, non-COVID-19) during hospitalization will be calculated using patient electronic health record data. Vaccine eligibility at hospital admission will be determined based upon the patient's age and, if applicable, underlying medical conditions or treatment regimens, per American Academy of Pediatrics recommendations for routine childhood vaccination.

Interventions

  • BEHAVIORAL PIVOT-IN
  • OTHER Standardized Vaccine Eligibility Screening

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2026-04
Est. Completion 2027-02
Phase NA
Seattle Children's Hospital

168 total trials

What is known before NCT07552857 opens enrollment

NCT07552857 is an interventional study that assigns participants to a tested intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% higher).

The record links to 0 conditions, and to 2 interventions - of which PIVOT-IN is the first listed.

NCT07552857 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07552857 about?

NCT07552857 is a clinical study titled "A Vaccine Communication Training Intervention for Pediatric Inpatient Clinicians". This study will examine a novel stakeholder-informed intervention to identify vaccine-eligible children and promote evidence-based clinician vaccine communication with families with the goal of increasing vaccine uptake during hospitalization.

What is the current status of trial NCT07552857?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2026-04. Estimated completion is 2027-02.

What interventions are being tested in trial NCT07552857?

The interventions under investigation include: PIVOT-IN (BEHAVIORAL), Standardized Vaccine Eligibility Screening (OTHER).

Who is sponsoring clinical trial NCT07552857?

This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07552857's enrollment target sits among peer trials

2,000 52nd of 2000 higher than 1,947 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  • NCT00138931 · 2,000 participants

    Genetics of Cardiovascular and Neuromuscular Disease

  • NCT00288119 · 2,000 participants

    Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07552857, the US trial registry maintained by the National Library of Medicine. NCT07552857 (large enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.